iShares Trust - iShares Biotechnology ETF
US ˙ NasdaqGM ˙ US4642875565

SecurityIBB / iShares Trust - iShares Biotechnology ETF
InstitutionJ. Goldman & Co LP
Latest Disclosed Ownership2,301 shares
Latest Disclosed Value $ 388,524
J. Goldman & Co LP ownership in IBB / iShares Trust - iShares Biotechnology ETF

On May 15, 2026 - J. Goldman & Co LP filed a 13F-HR form disclosing ownership of 2,301 shares of iShares Trust - iShares Biotechnology ETF (US:IBB) valued at $388,524 USD as of March 31, 2026. The entity filed a previous 13F-HR on November 14, 2025 disclosing 0 shares of iShares Trust - iShares Biotechnology ETF. The current value of the position is $385,418 USD.

J. Goldman & Co LP has a history of taking positions in derivatives of the underlying security (IBB) in the form of stock options. The firm currently holds call options representing 30,000 of underlying shares valued at $5,065,500 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

IBB / iShares Trust - iShares Biotechnology ETF Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 2,301 2,301 389 0.0113
2025-11-14 2025-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 0 -5,600 -100.00 0 -100.00
2025-08-14 2025-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 5,600 5,600 708 0.0170
2024-11-14 2024-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 0 -10,000 -100.00 0 -100.00
2024-08-14 2024-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 10,000 10,000 1,373 0.0388
2021-11-15 2021-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 0 -2,556 -100.00 0 -100.00
2021-08-16 2021-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 2,556 363 16.55 418 26.67 0.0162
2021-05-17 2021-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 2,193 135 6.56 330 5.77 0.0106
2021-02-16 2020-12-31 13F ISHARES TR NASDAQ BIOTECH 464287556 2,058 2,058 312 0.0158
2018-02-16 2017-12-31 13F/A-1 ISHARES TR NASDAQ BIOTECH 464287556 0 -1,450 -100.00 0 -100.00
2017-11-14 2017-09-30 13F ISHARES TR NASDAQ BIOTECH 464287556 1,450 200 16.00 484 24.74 0.0244
2017-08-14 2017-06-30 13F ISHARES TR NASDQ BIOTEC ETF 464287556 1,250 1,250 388 0.0210
2016-08-15 2016-06-30 13F ISHARES TR NASDQ BIOTEC ETF 464287556 0 -500 -100.00 0 -100.00
2016-05-16 2016-03-31 13F ISHARES TR NASDQ BIOTEC ETF 464287556 500 500 130 0.0081
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F ISHARES TR ISHARES BIOTECH Call 30,000 5,066 n/a n/a n/a
2025-08-14 2025-06-30 13F ISHARES TR ISHARES BIOTECH Call 0 -100.00 0 -100.00 n/a n/a n/a
2025-05-15 2025-03-31 13F ISHARES TR ISHARES BIOTECH Call 40,000 89.57 5,116 83.43 n/a n/a n/a
2025-02-14 2024-12-31 13F ISHARES TR ISHARES BIOTECH Call 21,100 2,790 n/a n/a n/a
2022-11-14 2022-09-30 13F ISHARES TR ISHARES BIOTECH Call 0 -100.00 0 -100.00 n/a n/a n/a
2022-08-15 2022-06-30 13F ISHARES TR ISHARES BIOTECH Call 30,000 3,529 n/a n/a n/a
2016-08-15 2016-06-30 13F ISHARES TR NASDQ BIOTEC ETF Call 0 -100.00 0 -100.00 n/a n/a n/a
2016-05-16 2016-03-31 13F ISHARES TR NASDQ BIOTEC ETF Call 30,000 7,824 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F ISHARES TR ISHARES BIOTECH Put 0 -100.00 0 -100.00 n/a n/a n/a
2026-02-17 2025-12-31 13F ISHARES TR ISHARES BIOTECH Put 40,000 100.00 6,751 133.81 n/a n/a n/a
2025-11-14 2025-09-30 13F ISHARES TR ISHARES BIOTECH Put 20,000 233.33 2,887 280.37 n/a n/a n/a
2025-08-14 2025-06-30 13F ISHARES TR ISHARES BIOTECH Put 6,000 -79.59 759 -79.81 n/a n/a n/a
2025-05-15 2025-03-31 13F ISHARES TR ISHARES BIOTECH Put 29,400 29.52 3,760 25.29 n/a n/a n/a
2025-02-14 2024-12-31 13F ISHARES TR ISHARES BIOTECH Put 22,700 3,001 n/a n/a n/a
2024-08-14 2024-06-30 13F ISHARES TR ISHARES BIOTECH Put 0 -100.00 0 -100.00 n/a n/a n/a
2024-05-15 2024-03-31 13F ISHARES TR ISHARES BIOTECH Put 20,000 -82.64 2,744 -82.47 n/a n/a n/a
2024-02-14 2023-12-31 13F ISHARES TR ISHARES BIOTECH Put 115,200 15,650 n/a n/a n/a
2023-08-14 2023-06-30 13F ISHARES TR ISHARES BIOTECH Put 0 -100.00 0 -100.00 n/a n/a n/a
2023-05-15 2023-03-31 13F ISHARES TR ISHARES BIOTECH Put 35,000 4,521 n/a n/a n/a
2019-11-14 2019-09-30 13F ISHARES TR NASDAQ BIOTECH Put 0 -100.00 0 -100.00 n/a n/a n/a
2019-08-14 2019-06-30 13F ISHARES TR NASDAQ BIOTECH Put 40,000 4,364 n/a n/a n/a
2015-11-16 2015-09-30 13F ISHARES TR NASDQ BIOTEC ETF Put 0 -100.00 0 -100.00 n/a n/a n/a
2015-08-14 2015-06-30 13F ISHARES TR NASDQ BIOTEC ETF Put 16,000 5,904 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.